Level Biotechnology Inc. (3118.TWO)

TWD 32.0

(0.0%)

Market Cap (In TWD)

1.03 Billion

Revenue (In TWD)

660.61 Million

Net Income (In TWD)

62.9 Million

Avg. Volume

60.9 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
29.6-39.9
PE
-
EPS
-
Beta Value
0.551
ISIN
TW0003118006
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
-
Employee Count
-
Website
https://www.level.com.tw
Ipo Date
2008-08-20
Details
Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. It also markets and distributes biomedical precision equipment. In addition, the company provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. Further, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan.